IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

InflaRx N.V.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026

$1.45+0.13 (+9.85%)

Close on Oct 19, 2026

InflaRx N.V. revenue by segment

InflaRx does not break out revenue by segment, region or product in the tagged data of its filings for this period type.